Physician profile
Cameron Schaeffer
NPI 1386622363
$462.43
in general payments reported to CMS, 2019-2025
12 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Pediatric Urology provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $99.99 · 2021: $77.92 · 2022: $68.08 · 2023: $19.77 · 2024: $45.23 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $150.94 | 2021-2025 | |
| Cook Medical LLC | $99.99 | 2019 | |
| Ucb, INC. | $37.76 | 2022-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $30.45 | 2025 | Dupixent |
| Leo Pharma INC. | $21.86 | 2025 | Anzupgo |
| Convatec INC. | $21.49 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $20.89 | 2022 | |
| Biofrontera INC. | $19.77 | 2023 | Ameluz, Xepi, Bf-Rhodoled |
| Incyte Corporation | $16.75 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.29 | 2021 | |
| Lilly USA, LLC | $13.82 | 2022 | |
| Abbvie INC. | $13.42 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Schaeffer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.